Skip to main content

Research News

Pharma Courses
  • Sea Cucumbers Could Hold Key to Stopping Cancer Spread

    Sea cucumbers are the ocean's janitors, cleaning the seabed and recycling nutrients back into the water. But this humble marine invertebrate could also hold the key to stopping the spread of cancer.
  • SGLT2 Inhibitors linked to reduced risk of Atrial Fibrillation in type 2 Diabetes
    A new study published in the journal Diabetes, Obesity and Metabolism has found that sodium-glucose co-transporter-2 (SGLT2) inhibitors are associated with a reduced incidence of atrial fibrillation in patients with type 2 diabetes mellitus.
  • University of Barcelona team identifies DNA regions and key genes that activate liver regeneration
    The mammalian liver has an extraordinary regenerative capacity, capable of fully restoring its mass and function after injury or partial resection. A study led by researchers at the University of Barcelona has identified the DNA regions that activate the regeneration of this organ.
  • Clinical research on psychedelics gets a boost from new study
    Consensus on how mindset and surroundings shape therapy outcomes is an important step toward regulatory approval for use of drugs like MDMA and psilocybin in treatment of debilitating mental health conditions.
  • New mRNA Vaccine is More Effective and Less Costly to Develop, Pitt Study Finds
    A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in NPJ Vaccines.
  • Dapagliflozin found beneficial in fatty liver
    Dapagliflozin shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), with or without type 2 diabetes in a new clinical trial conducted in China.
  • Zika virus uses cells ‘self-care’ system to turn against host
    A new study reveals the biological secret to the Zika virus’s infectious success : Zika uses host cells own self-care system of clearing away useless molecules to suppress the host proteins that the virus has employed to get into those cells in the first place.
  • Researchers engineer a herpes virus to turn on T cells for immunotherapy
    T cells are front line defenders against pathogens, like viruses, and cancer because they can kill infected or malignant cells. Scientists have for years been trying different techniques to direct these immune cells to protect against disease. CAR-T therapy is one such example of prompting the body’s own immune system to attack certain forms of cancer using T cells
  • Novel Maneuver Helps Malaria Parasite Dodge the Immune System
    Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, sometimes for years. It turns out that the parasite, Plasmodium falciparum, can shut down a key set of genes, rendering itself immunologically invisible.
  • New molecular movie reveals how antibiotic resistance to fusidic acid works
    In a new article published in Nature communications, researchers from Uppsala Antibiotic Center, Uppsala University and SciLifeLab describe a fundamental mechanism of antibiotic resistance. What happens in a bacterium that is resistant to the antibiotic fusidic acid? With a stop-motion movie at the atomic level, they can show that the resistance protein FusB works nearly like a crowbar.
Subscribe to Research News